Modification of the activity of mitochondrial monoamine oxidases in vitro and in vivo

Area of Science:

• Biochemistry
• Pharmacology
• Neuroscience

Background:

• Monoamine oxidase (MAO) enzymes play crucial roles in neurotransmitter metabolism.
• Histamine is a key mediator in allergic reactions and physiological processes.
• Iproniazid is known to inhibit MAO activity.

Purpose of the Study:

• To investigate the effect of iproniazid on histamine deaminating activity (HDA) in brain mitochondria.
• To elucidate the mechanism behind iproniazid's antihistamine effects.

Main Methods:

• In vitro treatment of bovine brain mitochondrial membranes with iproniazid and MAO inhibitors.
• In vivo administration of iproniazid to mice and guinea pigs.
• Measurement of MAO activity, HDA, histamine, and 5-hydroxytryptamine levels.
• Assessment of iproniazid's effects on histamine-induced bronchoconstriction.

Main Results:

• Iproniazid significantly increased HDA while inhibiting MAO activity in vitro.
• Clorgyline, a selective MAO-A inhibitor, prevented the iproniazid-induced increase in HDA.
• In vivo, iproniazid markedly increased HDA in mouse and guinea pig brain mitochondria.
• Iproniazid decreased brain histamine levels and prevented histamine-induced bronchoconstriction in guinea pigs.

Conclusions:

• Iproniazid induces a reversible qualitative alteration in MAO-A, transforming it into a potent histamine-deaminating enzyme.
• This MAO-A transformation is responsible for iproniazid's observed antihistamine effects.
• The study reveals a novel mechanism for modulating histamine levels and responses through MAO-A activity.